Welcome to PsychU!

The Impact Of 2nd Generation Antipsychotic Side Effects On Functioning From Schizophrenia Patient Perspective: A Global Patient Centered Study

Schizophrenia is a significant cause of disability worldwide requiring lifelong use of first- and second-generation antipsychotic medication. Common side effects of second-generation antipsychotics include akathisia, sedation, metabolic abnormalities, weight gain, and sexual dysfunction. While the impact of having these side effects on patient discontinuation and overall adherence to therapy is accepted, less is known about their impact on daily functioning and emotional wellbeing.

Becky Wong, PharmD, MBA, is a Senior Medical Science Liaison for Otsuka Pharmaceutical Development & Commercialization, Inc. Her …

Join PsychU today at no cost for access to this and other premium content!

Join today for instant access to all PsychU content, events, and more!

Membership is free!

Disclaimer: PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka America Pharmaceutical, Inc. (OAPI). Specific PsychU programs may be supported by OPDC, OAPI and other committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsor or the sponsors of the specific PsychU program in which such opinions are expressed. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU's educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC and OAPI.

MRC2.CORP.X.04348 / MRC2.CORP.X.04349